Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of secukinumab on inflammatory linear verrucous epidermal naevus with a somatic mutation in CARD14.

Clinical and experimental dermatology - 21 May 2024

Zhao Xinrong, Miao Chaoyang, Xiang Xin, Liu Yuanxiang, Wang Zhaoyang, Chen Yunliu, Xu Zigang

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to CARD Signaling Adaptor Proteins
Share to Guanylate Cyclase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Membrane Proteins

Share to Mutation

Source

Identifiers

PMID: 38369846
DOI: 10.1093/ced/llae047

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of secukinumab on inflammatory linear verrucous epidermal naevus with a somatic mutation in CARD14.PMID 38369846Read ↗

Clinical response to ustekinumab in CARD14-associated papulosquamous eruption (CAPE) with a new missense mutation in CARD14: a case report and systematic review.Semantic proximity Read ↗

Successful use of secukinumab in Netherton syndromeSemantic proximity Read ↗

A novel variant with a severe phenotype in a patient with CARD14-associated papulosquamous eruption successfully treated with ixekizumab.Semantic proximity Read ↗

Tralokinumab shows clinical improvement in patients with prurigo nodularis-like phenotype atopic dermatitis: A multicenter, prospective, open-label case series study.Semantic proximity Read ↗

Secukinumab Therapy for Netherton Syndrome.Semantic proximity Read ↗

Beneficial effect of ustekinumab in familial pityriasis rubra pilaris with a new missense mutation in CARD14Semantic proximity Read ↗

Efficacy of dupilumab for controlling severe atopic dermatitis with dominant-negative CARD11 variant.Semantic proximity Read ↗

Familial inflammatory linear verrucous epidermal naevus in a father and daughter.Semantic proximity Read ↗

Impetigo herpetiformis with IL-36RN mutation successfully treated with secukinumab.Semantic proximity Read ↗

Immune checkpoint inhibitor associated lichenoid dermatitis mimicking erythema multiforme major with a germline variant in human leukocyte antigen-B15Semantic proximity Read ↗

Loss-of-function mutations in caspase recruitment domain-containing protein 14 (CARD14) are associated with a severe variant of atopic dermatitisSemantic proximity Read ↗

CARD14/CARMA2 Signaling and its Role in Inflammatory Skin DisordersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.